Shenzhen City publishes quality standards for drug use

The reporter learned from the Municipal Food and Drug Administration yesterday that the Shenzhen Food and Drug Administration and the Municipal Health Population Planning Commission jointly issued the inspection standards for the drug quality management of drug users. The standard serves as a new result of the centralized contact mechanism of the bureau and the health administrative department. The organic integration of medical quality management and drug quality management of drug regulatory departments seeks to clarify regulatory requirements through the joint development of inspection rules, jointly conduct inspections and form regulatory forces, optimize the allocation of regulatory resources, and improve regulatory effectiveness.

The "Standard" consists of three parts: the Chinese Medicine, Western Medicine and Community Health Center, the family planning service agency, the outpatient department, and the clinic. The three detailed rules aim at the characteristics of various drugs and their usage patterns. Quantified at 100 points, covering Chinese and Western pharmacies of hospitals, family planning service organizations, community health centers, clinics, clinics and other drug users, including the establishment of pharmaceuticals, staffing, facilities and equipment, drug purchase and acceptance, drug storage and maintenance, and hospital preparations. Special drug management and adverse reaction monitoring.

It is reported that the Municipal Health Population Planning Commission and the Municipal Drug Administration will organize joint inspections based on this standard, and the inspection results will be used as the assessment basis for the drug administration part of the overall performance evaluation of medical services for pharmaceutical use units. As to the problems found in the inspection process, the inspection team shall promptly point out and supervise the rectification.